Correction: Transcriptome Profiling of Peripheral Blood Cells Identifies Potential Biomarkers for Doxorubicin Cardiotoxicity in a Rat Model

by Valentina K. Todorova, Marjorie L. Beggs, Robert R. Delongchamp, Ishwori Dhakal, Issam Makhoul, Jeanne Y. Wei, V. Suzanne Klimberg
Published 2013-01-01

Correction: Transcriptome Profiling of Peripheral Blood Cells Identifies Potential Biomarkers for Doxorubicin Cardiotoxicity in a Rat Model.

by Valentina K. Todorova, Marjorie L. Beggs, Robert R. Delongchamp, Ishwori Dhakal, Issam Makhoul, Jeanne Y. Wei, V. Suzanne Klimberg
Published 2013-01-01

Transcriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat model.

by Valentina K Todorova, Marjorie L Beggs, Robert R Delongchamp, Ishwori Dhakal, Issam Makhoul, Jeanne Y Wei, V Suzanne Klimberg
Published 2012-01-01

Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model

by Valentina K. Todorova, Eric R. Siegel, Yihong Kaufmann, Asangi Kumarapeli, Aaron Owen, Jeanne Y. Wei, Issam Makhoul, V. Suzanne Klimberg
Published 2020-02-01

Comparison of outcomes between metaplastic and triple-negative breast cancer patients

by Praveen Polamraju, Waqar Haque, Kevin Cao, Vivek Verma, Mary Schwartz, V. Suzanne Klimberg, Sandra Hatch, Polly Niravath, E. Brian Butler, Bin S. Teh
Published 2020-02-01

Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.

by Valentina K Todorova, Issam Makhoul, Eric R Siegel, Jeanne Wei, Annjanette Stone, Weleetka Carter, Marjorie L Beggs, Aaron Owen, V Suzanne Klimberg
Published 2016-01-01

Comparison between Freeze-dried and Ready-to-use AlloDerm in Alloplastic Breast Reconstruction

by James C. Yuen, MD, Connie J. Yue, BA, Stephen W. Erickson, PhD, Shannon Cooper, APN, Cristiano Boneti, MD, Ronda Henry-Tillman, MD, Suzanne Klimberg, MD
Published 2014-03-01

Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

by Issam Makhoul, Valentina K Todorova, Eric R Siegel, Stephen W Erickson, Ishwori Dhakal, Vinay R Raj, Jeannette Y Lee, Mohammed S Orloff, Robert J Griffin, Ronda S Henry-Tillman, Suzanne Klimberg, Laura F Hutchins, Susan A Kadlubar
Published 2017-01-01